DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Moore KN, Secord AA, Geller MA. et al.
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol 2019;
20: 636-648
doi:10.1016/S1470-2045(19)30029-4
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.